Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
7.35
0.00 (0.00%)
Dec 5, 2025, 4:00 PM EST - Market closed
Actuate Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Cash & Equivalents | 16.92 | 8.64 | 2.96 | 20.45 |
| Cash & Short-Term Investments | 16.92 | 8.64 | 2.96 | 20.45 |
| Cash Growth | 25.15% | 192.08% | -85.53% | - |
| Prepaid Expenses | 0.52 | 0.57 | 0.04 | 0.03 |
| Total Current Assets | 17.44 | 9.21 | 3 | 20.48 |
| Other Long-Term Assets | - | 0.11 | - | - |
| Accounts Payable | 1.25 | 1.92 | 3.42 | 2.13 |
| Accrued Expenses | 5.13 | 6.88 | 3.5 | 2.21 |
| Total Current Liabilities | 6.37 | 8.8 | 6.92 | 4.34 |
| Other Long-Term Liabilities | 0.4 | 0.41 | 0.54 | 0.49 |
| Common Stock | 0 | 0 | 0 | 0 |
| Additional Paid-In Capital | 160.99 | 132.48 | 5.47 | 5.04 |
| Retained Earnings | -150.05 | -132.38 | -105.09 | -80.35 |
| Total Common Equity | 10.94 | 0.1 | -99.63 | -75.31 |
| Total Liabilities & Equity | 17.71 | 9.32 | 3 | 20.48 |
| Net Cash (Debt) | 16.92 | 8.64 | 2.96 | 20.45 |
| Net Cash Growth | 25.15% | 192.08% | -85.53% | - |
| Net Cash Per Share | 0.85 | 1.03 | 2.06 | 16.89 |
| Filing Date Shares Outstanding | 23.24 | 19.53 | 1.69 | 1.21 |
| Total Common Shares Outstanding | 23.24 | 19.53 | 1.69 | 1.21 |
| Working Capital | 11.07 | 0.41 | -3.93 | 16.14 |
| Book Value Per Share | 0.47 | 0.01 | -58.93 | -62.21 |
| Tangible Book Value | 10.94 | 0.1 | -99.63 | -75.31 |
| Tangible Book Value Per Share | 0.47 | 0.01 | -58.93 | -62.21 |
Source: S&P Capital IQ. Standard template.
Financial Sources.